bpc 157 approval status fda panel backs compounded BPC-157, KPV peptides in win for RFK Jr A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! 83% of peptide aware Americans want the FDA to make peptides more accessible AOL The FDA cracked down on BPC 157 and now the biohackers are losing their minds Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank

SKU: 9212625880 · From creatorsinfotech.com